Care at UCLA for patients in need of bone marrow transplantation services are provided by the Bone Marrow/Stem Cell Transplantation Program.
As part of the Division of Transplantation Services at UCLA the Program provides for patients with hematologic malignancies receiving chemotherapy and those patients for whom transplantation is the therapy of choice. The treatment of blood and marrow cancers include currently available therapies, investigational drugs and treatments, as well as stem cell transplantation. Our physicians meet weekly to discuss individual treatment approaches as part of developing a coordinated treatment recommendation.
For decades, this comprehensive program has provided a full range of services as a local, regional, national and international referral center for transplantations for selected malignancies:
- Acute and chronic leukemias
- Aplastic anemia
- Breast cancer
- Congenital immunodeficiency diseases
- Growth factors
- Hodgkin's disease
- Metabolic diseases of childhood
- Multiple myeloma
- Ovarian cancer
- Testicular cancer
- Unrelated-donor bone marrow transplantation
The mission of the Bone Marrow/Stem Cell Transplantation Program is to find new and innovative treatments for malignancies and expanding the effectiveness and applicability of bone marrow transplantation through such means as biologic response modifiers, growth factors and chemotherapeutic agents.
Clinical trials are carefully controlled research studies in which cancer patients help doctors and scientists find ways to improve health and cancer care, and to make sure the treatments are safe and effective. Each study is designed to address and answer specific scientific questions and to find better ways to prevent, diagnose or treat cancer. A clinical trial is one of the final stages resulting from the research conducted during intensive and lengthy laboratory studies.
Clinical trials involving chemotherapy with or without bone marrow transplantation for patients in remission or relapse are available using allogeneic, autologous and unrelated donors. Transplant programs using bone marrow or peripheral blood stem cells are also available.
If you are interested in finding out more about these studies, search our listings of currently open clinical trials.
For more information on bone marrow transplantation services at UCLA, visit the following website: